Skip To Main Content
Manas Mahale on Muck Rack

Manas Mahale

As seen in: Nature, BioRxiv
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Manas

Contact Manas, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Artificial intelligence in drug discovery — what it is, where we stand and the path forward

|
By Andreas Bender, Morgan Thomas, Jack Scannell, David Shaywitz, Gian Marco Ghiandoni, Joe G. Greener, Lavinia-Lorena Pruteanu, Rachel Jacobson, Koichi Handa, Mariko Hirano, Srijit Seal, Manas Mahale, Marco Schmidt Verified, Tim Ahfeldt, Francesca Grisoni, Isidro Cortes-Ciriano
| Nature Verified
Abstract Artificial intelligence (AI) in drug discovery has attracted increasing interest over the past decade. It is now time for a critical review of progress in the field: where did we advance — and where are we yet to see impact — when it comes to what matters in drug discovery, which is to deliver safer and more efficacious medicines to patients faster?
Open in Who Shared Issue with article?

Improved Detection of Drug-Induced Liver Injury by Integrating Predicted in vivo and in vitro Data

|
By Srijit Seal, Dominic Williams, Layla Hosseini-Gerami, Manas Mahale
| BioRxiv
Abstract Drug-induced liver injury (DILI) has been significant challenge in drug discovery, often leading to clinical trial failures and necessitating drug withdrawals. The existing suite of in vitro proxy-DILI assays is generally effective at identifying compounds with hepatotoxicity.
Open in Who Shared Issue with article?
See all 2 articles